Skip to main content
CTEV logo

CTEV · Claritev Corp · Metrics

Track CTEV — free
$18.28 -0.75 (-3.94%) At close · Nov 20 Play latest call Q3 2026 earnings call transcript
Market Cap
$312.13M
Shares
17.07M
Volume · Nov 20 246.97K Avg daily vol (3M) 210.86K

CTEV metrics

91 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$18.28
Market cap
$312.13M

Price action

23 metrics
Price change (1W)
-31.8%
Price change (30D)
-22.2%
Price change (3M)
-51.0%
Price change (6M)
-15.6%
Price change (YTD)
-57.2%
Price change (1Y)
-59.6%
Trailing year
Price change (5Y)
—
52-week high
$54.87
52-week low
$13.47
Change from 52-week high
-66.7%
Change from 52-week low
+35.7%
Annualized volatility
117.2%
Annualized volatility (3M)
88.7%
Implied volatility (30D)
105.5%
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
2.3
RSI (14D)
34.4
Price vs SMA 50
-25.8%
Price vs SMA 200
-27.8%
Avg volume (3M)
210,863
Relative volume
1.2
Average dollar volume
$5.55M

Company

3 metrics
Sector
Healthcare
Industry
Health Information Services
Shares outstanding
17.07M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
4.9×
reciprocal yield 20.5%
EV / EBITDA
10.1×
reciprocal yield 9.9%
EV / EBIT
115.0×
reciprocal yield 0.9%
P / sales
0.3×
reciprocal yield 325.8%
P / book
—
FCF yield
-8.9%
TTM · current market cap
Buyback yield
1.1%
P / FCF
—
P / operating cash flow
2.4
reciprocal yield 42.1%
Earnings yield
-88.1%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
5.3×
reciprocal yield 19.0%
EV / revenue historical average (5Y)
5.5×
reciprocal yield 18.3%
EV / EBIT historical average (3Y)
134.5×
reciprocal yield 0.7%
EV / EBIT historical average (5Y)
82.6×
reciprocal yield 1.2%
EV / EBITDA historical average (3Y)
27.9×
reciprocal yield 3.6%
EV / EBITDA historical average (5Y)
28.2×
reciprocal yield 3.5%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
1.1%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-11-09

Profitability

9 metrics
Gross margin
—
Operating margin
4.2%
Trailing 12 months
Net margin
-27.1%
Gross profit (TTM)
—
Operating profit (TTM)
$43.05M
Net income (TTM)
−$275.14M
Trailing 12 months
Diluted EPS (TTM)
$-16.42
FCF margin
-2.7%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$60.56
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
$2.53
EBITDA per diluted share (TTM)
$29.04
Net income per diluted share (TTM)
$-16.41
Operating cash flow per diluted share (TTM)
$7.80
Free cash flow per diluted share (TTM)
$-1.67
Capital expenditures per diluted share (TTM)
$9.47
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$1.74
Book value per share
$-20.30

Growth

11 metrics
Revenue growth YoY
+9.1%
Year over year
Net income growth YoY
—
Revenue (TTM)
$1.02B
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+3.0%
Year over year · more shares
Revenue CAGR (3Y)
-3.7%
Revenue CAGR (5Y)
+0.6%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
—
Return on assets
-5.9%
Debt / equity
—
Current ratio
1.2
EBITDA (TTM)
$488.06M
Free cash flow (TTM)
−$27.82M
Quick ratio
1.2
Interest coverage
0.1
Net debt / EBITDA
9.5
Return on invested capital
—
Trailing 12 months
Net cash
−$4.64B
Latest balance sheet
Cash & equivalents
$10.14M
Total assets
$4.68B
Total debt
$4.65B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$131.31M
Capital expenditures (TTM)
$159.13M
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$29.27M
R&D / revenue
—
Stock compensation / revenue
2.9%

Ownership (13F)

9 metrics
13F filers
106
13F filer change QoQ
+5
Institutional ownership
88.8%
Conviction holders (share of 13F filers)
5.7%
Crowding (high-turnover and private-fund holders)
32.8%
Private-fund adviser ownership
32.6%
Active holders' share change QoQ
+12.2%
Holder tenure
7.1
Price vs estimated holder cost
-27.9%

Ownership (registered funds)

1 metrics
Index-fund ownership
8.3%

Short interest

3 metrics
Short interest
4.5%
Latest settlement · 2.9 days to cover
Days to cover
2.9d
Short-squeeze score
44 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$1.83M
Insider-sentiment score
29 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1793229 CUSIP 62548M209 13F (30d) 104 filings 98 filers Visit website Investor relations